Senseonics, the maker of Eversense, the world’s first long-term CGM system, announced the integration of Eversense CGM data into the Glooko diabetes data management platform.
Related Cellnovo Launches New Mobile App that Connects Directly to CGM Data via HealthKit
With this integration, Eversense CGM data will be allowed to be synced into Glooko’s platform directly from the Senseonics cloud. Eversense users will be able to view historical glucose and related data both in Glooko’s Mobile and Web Apps while continuing to get real-time readings from their Eversense Mobile App. Healthcare professionals can now view their patients’ data in the Glooko Population Tracker in interactive reports alongside other data residing in Glooko, reports Business Wire.
“Glooko has a large database of millions of users who are now able to see a clearer picture of their glucose profiles by integrating Eversense CGM data,” said Tim Goodnow, President and CEO of Senseonics. “With personalized medicine at the forefront of health care, data integration between Eversense CGM and Glooko helps provide customized data for users, as well as healthcare providers. We believe this information can empower our community to help manage their diabetes with new insights and actions and, ultimately, improve lives.”
The Eversense CGM System comprises of a fluorescence-based sensor, a Bluetooth transmitter for data communication and a mobile app that displays glucose levels, trends and alerts. The sensor lasts up to 3 months and needs to be inserted subcutaneously in the upper arm by a physician in a brief in-office procedure. The system is also first to feature a smart transmitter that provides wearers with discreet on-body vibratory alerts for high and low glucose. Traditional CGMs require patients to self-administer insertions of the sensors weekly or biweekly. Additionally, CGM’s transmitter can be removed and recharged without discarding the sensor.
Related Medtronic’s Smartphone-Connected CGM System Gets FDA Approval
“We are excited to launch support for the breakthrough Eversense CGM on the Glooko platform,” said Russ Johannesson, CEO of Glooko. “Eversense is an innovative solution for making glucose data more accessible, and we feel users will get tremendous value out of seeing this data correlated with food, activity, and medication information they log in Glooko to help them make treatment decisions.”
